Nucala - direct healthcare professional communication (DHPC)

Mepolizumab

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Shortage of Nucala (mepolizumab) Pre-Filled Pen (EU/1/15/1043/003, EU/1/15/1043/004)

Dissemination date: 23/01/2021Summary:

Direct healthcare professional communication (DHPC): Shortage of Nucala (mepolizumab) Pre-Filled Pen (EU/1/15/1043/003, EU/1/15/1043/004)

Key facts

• Medicine name:
  Nucala
• Active substance:
  Mepolizumab
• Therapeutic area (MeSH):
  Asthma
• DHPC type:
  Medicine shortage
• Human ATC codes:
  R03DX09
• Dissemination date:
  23/01/2021